02:59 PM EST - Oncolytics Biotech Inc : Announces the appointment of Steve Glover to its Board of Directors and the promotion of John McAdory to Chief Operating Officer. Mr. Glover brings significant public company leadership and transaction experience to Oncolytics, including serving as Chairman of Ambrx Biopharma during its acquisition by Johnson & Johnson in a transaction valued at approximately $2 billion. Oncolytics Biotech Inc
shares N.ONCY are trading off $0.13 at $0.93.
Full Press Release: https://www.baystreet.ca/quotedata/quote.aspx?ticker=ONCY&qmodStoryID=8228781316283300
